Literature DB >> 15932065

Glucose transporter 1, distribution in the brain and in neural disorders: its relationship with transport of neuroactive drugs through the blood-brain barrier.

Xiuli Guo1, Meiyu Geng, Guanhua Du.   

Abstract

Facilitative glucose transport is mediated by one or more of the members of the closely related glucose transporter (GLUT) family. Thirteen members of the GLUT family have been described thus far. GLUT1 is a widely expressed isoform that provides many cells with their basic glucose requirement. It is also the primary transporter across the blood-brain barrier. This review describes the distribution and expression of GLUT1 in brain in different pathophysiological conditions including Alzheimer's disease, epilepsy, ischemia, or traumatic brain injury. Recent investigations show that GLUT1 mediates the transport of some neuroactive drugs, such as glycosylated neuropeptides, low molecular weight heparin, and D-glucose derivatives, across the blood-brain barrier as a delivery system. By utilizing such highly specific transport mechanisms, it should be possible to establish strategies to regulate the entry of candidate drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15932065     DOI: 10.1007/s10528-005-1510-5

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  31 in total

Review 1.  Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.

Authors:  Simon G Patching
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

Review 2.  Blood-brain barrier: structural components and function under physiologic and pathologic conditions.

Authors:  Yuri Persidsky; Servio H Ramirez; James Haorah; Georgette D Kanmogne
Journal:  J Neuroimmune Pharmacol       Date:  2006-07-06       Impact factor: 4.147

Review 3.  Genetic studies of myelomeningocele.

Authors:  Kazuaki Shimoji; Takaoki Kimura; Akihide Kondo; Yuichi Tange; Masakazu Miyajima; Hajime Arai
Journal:  Childs Nerv Syst       Date:  2013-09-07       Impact factor: 1.475

4.  Enhanced expression of the sweet taste receptors and alpha-gustducin in reactive astrocytes of the rat hippocampus following ischemic injury.

Authors:  Yoo-Jin Shin; Joo-Hee Park; Jeong-Sun Choi; Myung-Hoon Chun; Young Wha Moon; Mun-Yong Lee
Journal:  Neurochem Res       Date:  2010-07-02       Impact factor: 3.996

Review 5.  Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights.

Authors:  Dharmini C Mehta; Jennifer L Short; Sarah N Hilmer; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

6.  A 10 bp deletion polymorphism and 2 new variations in the GLUT1 gene associated with meningomyelocele.

Authors:  Clint M Cormier; Kit Sing Au; Hope Northrup
Journal:  Reprod Sci       Date:  2010-12-06       Impact factor: 3.060

Review 7.  Age-associated physiological and pathological changes at the blood-brain barrier: A review.

Authors:  Franciska Erdő; László Denes; Elizabeth de Lange
Journal:  J Cereb Blood Flow Metab       Date:  2016-11-11       Impact factor: 6.200

8.  Analysis of glucose transporter topology and structural dynamics.

Authors:  David M Blodgett; Christopher Graybill; Anthony Carruthers
Journal:  J Biol Chem       Date:  2008-11-03       Impact factor: 5.157

9.  Normal glucose uptake in the brain and heart requires an endothelial cell-specific HIF-1α-dependent function.

Authors:  Yan Huang; Li Lei; Dinggang Liu; Ion Jovin; Raymond Russell; Randall S Johnson; Annarita Di Lorenzo; Frank J Giordano
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-09       Impact factor: 11.205

Review 10.  Blood-brain barrier-on-a-chip: Microphysiological systems that capture the complexity of the blood-central nervous system interface.

Authors:  Duc Tt Phan; R Hugh F Bender; Jillian W Andrejecsk; Agua Sobrino; Stephanie J Hachey; Steven C George; Christopher Cw Hughes
Journal:  Exp Biol Med (Maywood)       Date:  2017-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.